From Annual report Fy 22-23. “In recent years, the Company has
intensified its focus on R&D, recognising its
pivotal role in driving innovation and growth.
In line with this commitment, the Company
is currently in the process of establishing a
state-of-the-art R&D biotechnology plant.
The projected capital expenditure (capex) for
this venture is expected to range from Rs 25
crore to Rs 30 crore on a year-on-year basis. By
investing significantly in R&D, the Company
aims to enhance its research capabilities
and propel the development of cutting-edge
seed solutions, ultimately contributing to the
advancement of the agricultural sector and
the Company’s sustainable growth”
Subscribe To Our Free Newsletter |